What Researchers Did
The tenth European Consensus Conference on Hyperbaric Medicine revised the European Committee on Hyperbaric Medicine (ECHM) list of accepted indications for hyperbaric oxygen treatment (HBOT) using the modified GRADE and DELPHI systems.
What They Found
The conference established three types of indications for HBOT: Type 1, strongly indicated as a primary treatment; Type 2, suggested with acceptable evidence; and Type 3, possible/optional but not yet strongly supported. These types were further categorized by three levels of evidence: A for sufficient randomized controlled trials (RCTs), B for some RCTs and expert consensus, and C for ample international expert consensus when RCTs are not feasible.
What This Means for Canadian Patients
This consensus provides a structured, evidence-based framework for evaluating hyperbaric oxygen treatment (HBOT) indications, which could inform clinical practice and guidelines in Canada. Canadian patients might benefit from clearer, more standardized criteria for when HBOT is recommended, suggested, or considered optional based on the strength of evidence.
Canadian Relevance
This study has no direct Canadian connection as it is a European consensus conference.
Study Limitations
A limitation is that the consensus relies on the interpretation of existing evidence, which may be insufficient for some indications, and does not present new primary research.